PE/VC Fundraising - Acquisitions & Exits - Funding Rounds - Tell us about your Deals - Sign up for Newsletter

Abingworth

NousCom Raises €42M Serie B Financing

Abingworth backed MEDIAN Technologies in €19,599,996 share capital increase

UK-based international life sciences investment group, Abingworth, raises $105m

UK-based Kesios Therapeutics closes a £19M Series A financing from Imperial Innovations, SV Life Sciences and Abingworth

MEDIAN Technologies, a medical imaging solutions provider, raises €19.8M in investment led by Abingworth

CRISPR Therapeutics, a biopharmaceutical company, raises additional $64M

Chiasma, a Biopharma Company Developing Octreotide Capsules, Announces Completion of $70M Series E Financing

Pixium Vision, a provider of Vision Restoration Systems for patients who have lost their sight, raises €34.5 million in successful IPO

Proteon Therapeutics, a biopharmaceutical company, Announces $45 Million of Series D Financing

Wilson Therapeutics Secures $40 Million Private Financing To Advance Late Stage Development Program For Wilson’s Disease